» Articles » PMID: 23023935

MicroRNA-29a Suppresses Cell Proliferation by Targeting SPARC in Hepatocellular Carcinoma

Overview
Journal Int J Mol Med
Specialty Genetics
Date 2012 Oct 2
PMID 23023935
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

In the present study, we constructed a lentivirus vector encoding the miR-29a precursor and established two stably infected cell lines, PLC-29a and 97L-29a. The overexpression of miR-29a was confirmed by TaqMan RT-PCR and significantly suppressed the growth of the hepatocellular carcinoma cell lines MHCC-97L and PLC. Dual-luciferase reporter assays indicated that the SPARC mRNA 3'UTR was directly targeted by miR-29a since the mutated 3'UTR was not affected. Silencing SPARC expression by RNAi knockdown resulted in a similar effect as miR-29a overexpression on hepatocellular carcinoma (HCC) cell growth regulation. Anti-miR-29a oligonucleotides (AMOs) upregulated the levels of SPARC in the HCC cells. The phosphorylation of AKT/mTOR downstream of SPARC was inhibited in miR-29a-overexpressing HCC cells. We further examined and compared the expression levels of miR-29a in HCC tissues and the corresponding nearby non-cancerous liver tissues of 110 patients with HCC by qRT-PCR, and significantly lower expression of miR-29a was observed in the tissues affected by HCC. Our findings demonstrate that the expression of miR-29a is important in the regulation of the SPARC-AKT pathway and HCC growth.

Citing Articles

SPARC: a potential target for functional nanomaterials and drugs.

Jiang S, Sun H, Li S, Zhang N, Chen J, Liu J Front Mol Biosci. 2023; 10:1235428.

PMID: 37577749 PMC: 10419254. DOI: 10.3389/fmolb.2023.1235428.


The Role of miR-29s in Human Cancers-An Update.

Nguyen T, Suman K, Nguyen T, Nguyen H, Do D Biomedicines. 2022; 10(9).

PMID: 36140219 PMC: 9495592. DOI: 10.3390/biomedicines10092121.


The role of SPARC (secreted protein acidic and rich in cysteine) in the pathogenesis of obesity, type 2 diabetes, and non-alcoholic fatty liver disease.

Atorrasagasti C, Onorato A, Mazzolini G J Physiol Biochem. 2022; 79(4):815-831.

PMID: 36018492 DOI: 10.1007/s13105-022-00913-5.


Novel Methylation Biomarkers for Colorectal Cancer Prognosis.

Gutierrez A, Demond H, Brebi P, Ili C Biomolecules. 2021; 11(11).

PMID: 34827720 PMC: 8615818. DOI: 10.3390/biom11111722.


Modeling the Adsorption of the miR-29a Cancer Biomarker on a Graphene Quantum Dot.

Kuntip N, Japrung D, Pongprayoon P ACS Omega. 2021; 6(33):21764-21772.

PMID: 34471778 PMC: 8388069. DOI: 10.1021/acsomega.1c03404.